Security Snapshot

AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) Institutional Ownership

CUSIP: G29687103

13F Institutional Holders and Ownership History from Q1 2023 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

204

Shares (Excl. Options)

73,357,625

Price

$21.55

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Ordinary Shares, nominal value $0.01 per share
Symbol
AVDL
Shares outstanding
95,992,895
Price per share
$21.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
73,357,625
Total reported value
$1,580,599,280
% of total 13F portfolios
0.01%
Share change
-5,976,998
Value change
-$27,117,037
Number of holders
204
Price from insider filings
$21.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share is tracked under CUSIP G29687103.
  • 204 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 204 to 1 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,580,599,280 to $426.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 204 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP G29687103?
CUSIP G29687103 identifies AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $59,674,993 6,742,480 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.7% $49,243,692 5,564,259 The Vanguard Group 30 Jun 2025
JANUS HENDERSON GROUP PLC 1.9% -72% $39,176,620 -$120,413,722 1,823,865 -75% JANUS HENDERSON GROUP PLC 31 Dec 2025
BRANDES INVESTMENT PARTNERS, LP 0.2% -95% $4,700,576 -$117,105,674 218,835 -96% BRANDES INVESTMENT PARTNERS, LP 31 Dec 2025

As of 31 Dec 2025, 204 institutional investors reported holding 73,357,625 shares of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL). This represents 76% of the company’s total 95,992,895 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.3% 7,041,102 +0.97% 0% $151,735,747
VANGUARD GROUP INC 6.1% 5,864,781 +4.6% 0% $126,386,030
GENDELL JEFFREY L 5% 4,769,357 -10% 1.8% $102,779,643
Weiss Asset Management LP 4.7% 4,515,114 1.5% $97,300,707
TIG Advisors, LLC 4% 3,859,122 4% $83,164,079
TUDOR INVESTMENT CORP ET AL 3.1% 2,983,541 +6718% 0.35% $64,295,309
FIL Ltd 2.9% 2,822,777 0.05% $60,830,844
Vivo Capital, LLC 2.8% 2,684,109 0% 3.7% $57,842,549
STATE STREET CORP 2.4% 2,278,301 -0.62% 0% $49,097,387
GEODE CAPITAL MANAGEMENT, LLC 2.2% 2,156,356 -0.89% 0% $46,477,231
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.1% 2,048,585 2% $44,147,007
WEALTH EFFECTS LLC 2% 1,891,917 -17% 13% $40,770,806
JANUS HENDERSON GROUP PLC 1.9% 1,823,865 -75% 0.02% $39,300,130
Pentwater Capital Management LP 1.8% 1,684,000 0.26% $36,290,200
KENNEDY CAPITAL MANAGEMENT LLC 1.2% 1,194,197 -27% 0.55% $25,734,945
WATER ISLAND CAPITAL LLC 1.1% 1,087,117 2.9% $23,427,370
Krensavage Asset Management, LLC 0.89% 855,860 -10% 6.5% $18,444,000
NORTHERN TRUST CORP 0.83% 797,200 -7% 0% $17,179,660
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 793,752 -0.72% 0% $17,105,356
Hudson Bay Capital Management LP 0.81% 782,239 0.1% $16,857,250
CITADEL ADVISORS LLC 0.8% 770,232 -27% 0.01% $16,598,500
KOTLER KEVIN 0.77% 741,343 0% 12% $15,975,942
Woodline Partners LP 0.73% 702,066 -22% 0.06% $15,129,522
NEUBERGER BERMAN GROUP LLC 0.71% 684,321 -0.68% 0.01% $14,747,117
GOLDMAN SACHS GROUP INC 0.68% 655,058 +25% 0% $14,116,500

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 20 $426 -$99,485,516 $21.30 1
2025 Q4 73,357,625 $1,580,599,280 -$27,117,037 $21.55 204
2025 Q3 79,038,211 $1,206,765,098 -$19,096,496 $15.27 183
2025 Q2 80,502,710 $712,425,370 +$33,247,786 $8.85 166
2025 Q1 77,015,539 $605,345,850 -$36,026,238 $7.83 169
2024 Q4 78,709,574 $827,347,590 +$46,727,000 $10.51 153
2024 Q3 73,371,084 $962,302,695 +$83,134,728 $13.12 169
2024 Q2 66,234,240 $931,472,460 +$905,737,723 $14.06 142
2024 Q1 1,624,846 $27,443,649 +$27,443,649 $16.89 7
2023 Q2 0 $0 -$4,287 $21.30 0
2023 Q1 468 $4,287 +$4,287 $9.16 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .